Anti-BCL9L aptamer SELEX Service(Cat#: CTApt-1925)

This is an aptamer development services to screening aptamers binds to the BCL9L with an affinity of 1nM~1μM.

Specific Inquiry 
Size
5’ Modification
 
3’ Modification
 
Add To
Online Inquiry

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

TOP
Summary

Specifications
Target Category Protein
Target BCL9L
Alternative Names BCL9 Like; DLNB11; B-Cell CLL/Lymphoma 9-Like Protein; B-Cell Lymphoma 9-Like Protein; B Cell CLL/Lymphoma 9 Like; BCL9-Like Protein; Protein BCL9-2; B9L; Nuclear Co-Factor Of Beta-Catenin Signalling; BCL9-2; Bcl9-2; BCL9L
Gene ID 283149
UniProt ID Q86UU0
Target Overview BCL9L (BCL9 Like) is a Protein Coding gene. Diseases associated with BCL9L include Acinar Cell Cystadenocarcinoma. Among its related pathways are Signaling by GPCR and Wnt / Hedgehog / Notch. Gene Ontology (GO) annotations related to this gene include transcription coactivator activity and beta-catenin binding. An important paralog of this gene is BCL9.
Chemical Modification N/A
Type DNA
Length 20-80 nt
Affinity (Kd) 1nM~1μM
Binding Conditions/Buffer PBS; buffer system with Serum; other
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry